J0595 HCPCS Level II code: Injection, butorphanol tartrate, 1 mg
J0595 is the HCPCS code for “Injection, butorphanol tartrate, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0595Injection, butorphanol tartrate, 1 mg
Short description: Butorphanol tartrate 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J0595 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Other drugs
- Added
- Jan 1, 2004
Where J0595 sits
- 1J codesDrugs administered other than orally
- 2Active code J0595Injection, butorphanol tartrate, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0595 mean?
J0595 is the HCPCS code for “Injection, butorphanol tartrate, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0595?
CMS lists J0595’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0595
All J codesJ0588Injection, incobotulinumtoxin a, 1 unitJ0589Injection, daxibotulinumtoxina-lanm, 1 unitJ0591Injection, deoxycholic acid, 1 mgJ0592Injection, buprenorphine hydrochloride, 0.1 mgJ0593Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)J0594injection, busulfan, 1 mgJ0596Injection, c1 esterase inhibitor (recombinant), ruconest, 10 unitsJ0597Injection, c-1 esterase inhibitor (human), berinert, 10 unitsJ0598Injection, c-1 esterase inhibitor (human), cinryze, 10 unitsJ0599Injection, c-1 esterase inhibitor (human), (haegarda), 10 unitsJ0600Injection, edetate calcium disodium, up to 1000 mgJ0601Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)